|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
The U.S. Opioid Crisis: What Every Regulatory Professional Absolutely, Positively Needs to Know
The opioid crisis is the stuff of daily headlines. But behind the headlines lurk serious implications for drugmakers, healthcare providers and other regulated firms.
But how should a drug firm respond now, before things get out of hand? (Think tobacco settlements.)
Lawyer and author Roseann B. Termini Esq. has answers. In an all-new presentation from FDAnews, Ms. Termini will address these hot-button issues:
The opioid crisis isn’t going away any time soon. Drugmakers and healthcare providers have a lot to lose if public opinion turns against them. Don’t take that risk. Start preparing now.
This presentation targets:
Within such organizations, job titles include:
Roseann B. Termini Esq. is an author and educator specializing in direct-to-consumer advertising and corporate accountability. As a lawyer she successfully litigated and prosecuted numerous cases involving food and drug law. As an educator she created online food and drug law courses at Widener University Law School. She was corporate counsel for a pharmaceutical company, founding board member of Pharmaceutical Health Services and is Vice Chair, Health Law Committee. She recently published New Edition Print and E-books — Food and Drug Law: Federal Regulation of Drugs, Biologics, Medical Devices, Foods, Dietary Supplements, Personal Care, Veterinary and Tobacco Products (2017) https://fortipublications.com
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing